siRNA-induced liver ApoB knockdown lowers serum LDL-cholesterol in a mouse model with human-like serum lipids
Open Access
- 1 June 2011
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 52 (6), 1084-1097
- https://doi.org/10.1194/jlr.m012872
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencingNucleic Acids Research, 2010
- Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatmentMolecular Therapy, 2010
- MicroRNA-like off-target transcript regulation by siRNAs is species specificRNA, 2009
- Pre-filtering improves reliability of Affymetrix GeneChips results when used to analyze gene expression in complex tissuesMolecular and Cellular Probes, 2008
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Potent and persistent in vivo anti-HBV activity of chemically modified siRNAsNature Biotechnology, 2005
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.JCI Insight, 1993
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Familial apolipoprotein E deficiency.JCI Insight, 1986
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959